A cationic iridium-catalyzed C2-alkylation of N-substituted indole derivatives with various alkenes has been developed, which selectively gives linear or branched 2-alkylindoles in high to excellent selectivity. This protocol relies on the use of the carbonyl group on the nitrogen atom of indole as a directing group: a linear product was predominant when an acetyl group was used as a directing group, and a branched product was predominant with a benzoyl group.
A cationic Ir(I)-tolBINAP complex catalyzed an enantioselective C-C bond formation initiated by secondary sp(3) C-H bond cleavage adjacent to a nitrogen atom. The reaction of 2-(alkylamino)pyridines with various alkenes gave chiral amines in good yields with high enantiomeric excesses.
Over the past few years, iridium
complexes have been widely used
in the direct functionalization of unactivated bonds. In the presence
of iridium catalysts, inactive C–H and N–H bonds have
been transformed into C–C and N–C bonds in dehydrative
alkylation using alcohols, allylation using allyl carbonates, and
alkylation using alkenes. Enantioselective variants of some reactions
have also been reported.
Azole derivatives were synthesized by iron-catalyzed oxidative reactions of azoles and ethers in good to excellent yields. A wide variety of azoles and ethers were selectively transformed into the corresponding oxidative coupling products under neutral reaction conditions.
A novel Pummerer-type reaction was developed via o-chloranil-mediated C-H bond oxidation. The reaction provides a simple and efficient method to construct sulfide derivatives. A Knoevenagel-type reaction was also achieved via multiple C-H bonds activation under neutral reaction conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.